Table 1.
The characteristics of failure in five patients with relapse after supine isocentric craniospinal irradiation (CSI)
Patient number | Diagnosis | Treatment after surgery | Site and time of failure |
---|---|---|---|
1 | Medulloblastoma | CSI 30 Gy, tumour bed 46 Gy plus chemotherapy | Primary site failure at 20 months |
2 | Medulloblastoma | CSI 30 Gy, tumour bed 55 Gy plus chemotherapy | T5–T6 spinal leptomeningeal metastasis at 24 months |
3 | Medulloblastoma | CSI 30 Gy, tumour bed 46.5 Gy plus chemotherapy | Primary site failure at 10 months |
4 | Ependymoma | CSI 30 Gy, tumour bed 60 Gy plus chemotherapy | Primary site progression at 3 months |
5 | Teratoma | CSI 30 Gy, tumour bed 60 Gy plus chemotherapy | T12–L1 spinal leptomeningeal metastasis at 18 months |